Lieff Cabraser Cipro Team Recognized as Honorees for AAI 2017 Antitrust Enforcement Awards

Lieff Cabraser Cipro Team Recognized as Honoree for AAI 2017 Antitrust Enforcement Awards

The American Antitrust Institute has announced its selection of leading practioners and economists to be recognized as honorees for the 2017 Antitrust Enforcement Awards. Lieff Cabraser’s team shared the AAI’s award for Outstanding Private Practice Antitrust Achievement, and partner Lin Chan won the Institute’s prestigious solo award for Outstanding Antitrust Litigation Achievement by a Young Lawyer. [Read more…]

Final Approval Granted to $225 Million Barr Labs Settlement in Cipro Antitrust Litigation

Final Approval Granted to $225 Million Barr Labs Settlement in Cipro Antitrust Litigation

On April 21, 2017, Judge Ronald L. Styn of the Superior Court of California granted final approval to a $225 million settlement with Barr Laboratories in the Cipro Antitrust litigation. Lieff Cabraser and co-counsel represent California consumers and third party payors in the class action lawsuit charging that Bayer Corporation, Barr Laboratories, and the HMR Defendants colluded to block consumer access to affordable, generic versions of Cipro through a massive $398.1 million payment by Bayer to Barr and other generic drug makers. [Read more…]

$225 Million Settlement Announced in Cipro Antitrust Litigation

$225 Million Settlement Announced in Cipro Antitrust Litigation

Lieff Cabraser, Zwerling, Schachter & Zwerling, LLP, and the Joseph Saveri Law Firm represent California consumers and third party payors in a class action lawsuit charging that Bayer Corporation, Barr Laboratories, and the HMR Defendants colluded to block consumer access to affordable, generic versions of Cipro through a massive $398.1 million payment by Bayer to Barr and other generic drug makers. [Read more…]

Levaquin and Cipro, Secret Killers via Aneurysm, Aortic Dissection

female doctor examining a teenage girl in her office

Hundreds of Americans with Minor Infections Are Dying Every Year from Aneurysms That May Have Been Caused by the Super-Antibiotics they Should Never Have Been Prescribed

A class of strong antibiotic drugs including Levaquin and Cipro prescribed widely to treat common bacterial infections like urinary tract infections, bronchitis, and sinusitis have been linked to significantly increased risks of potentially life-threatening aortic aneurysms and aortic dissections. [Read more…]

California Lawyer Recognizes Eric Fastiff, Brendan Glackin, and Dean Harvey With 2016 CLAY Award for Cipro Case

California Lawyer Recognizes Eric Fastiff, Brendan Glackin, and Dean Harvey With 2016 CLAY Award

Lieff Cabraser attorneys selected as California Lawyers of the Year for antitrust case against Bayer over anticompetitive pricing of the blockbuster antibiotic drug Ciproflaxacin, sold as Cipro

California Lawyer has selected Lieff Cabraser partners Eric Fastiff, Brendan Glackin, and Dean Harvey as recipients of its 20th annual California Lawyer Attorneys of the Year (CLAY) Award. The prestigious award is given to lawyers whose work had a significant impact in the preceding year. The team was recognized for their outstanding work on In re Cipro Cases I & II, JCCP 4154/4220, a case that led the California Supreme Court to resoundingly endorse the rights of consumers to challenge pharmaceutical “pay-for-delay” settlements under California competition law.

[Read more…]